Hazlett, Burt & Watson’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Hazlett, Burt & Watson's MDT Position: Q3 2026 in Review
Hazlett, Burt & Watson reduced its Medtronic (MDT) stake by 17% in Q3 2026, selling an estimated $15.6K and leaving 869 shares worth $74K. The position accounts for 0.02% of the portfolio, ranked #393.
Hazlett, Burt & Watson first reported a position in MDT in Q1 2022 and has held it in 19 quarters since. The position peaked at $225K in Q1 2022. 1,271 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Hazlett, Burt & Watson held 869 shares of Medtronic worth $74K as of Q3 2026.
- Hazlett, Burt & Watson sold 177 Medtronic shares in Q3 2026, an estimated $15.6K.
- Medtronic made up 0.02% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #393 holding.
- Hazlett, Burt & Watson first reported a position in Medtronic in Q1 2022 and has held it in 19 quarters since.
- Hazlett, Burt & Watson's Medtronic position peaked at $225K in Q1 2022.
- 1,271 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.